Patent · US Active

Influenza hemagglutinin and neuraminidase variants

US8333975B2 · kind B2 · utility

5Cited by
23References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2011
Grant dateDec 18, 2012
Priority date—
Expiry dateDec 16, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2760/16234
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.